“Delineating the underlying reasons for the population differences in gastric cancer incidence in the United States” With Meira Epplein, MD

“Delineating the underlying reasons for the population differences in gastric cancer incidence in the United States”

Meira Epplein, PhD

Co-Leader, Cancer Risk, Detection, and Interception (CRDI)

Duke Cancer Institute

Professor, Population Health Sciences and Medicine,

Duke University School of Medicine

Meira Epplein is Co-Leader of the Cancer Risk, Detection, and Interception Program of the Duke Cancer Institute and Professor of Population Health Sciences and Medicine at Duke University. She is a cancer epidemiologist interested in modifiable risk factors in underserved populations, with a focus on the association of infection and cancers. She has been PI of five grants from the NCI seeking to further our understanding of the diversity of the bacteria Helicobacter pylori, and host response to infection, and the association with gastrointestinal cancers. She is also involved in local initiatives to understand the prevalence of H. pylori in the community and to explore the opportunities for precision prevention of gastric cancer through targeted H. pylori eradication therapy.